DSN
REGN icon

D. Scott Neal’s Regeneron Pharmaceuticals REGN Stock Holding History

D. Scott Neal’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-8
Closed -$3K – 140
2018
Q1 		$3K Hold
8
– – ﹤0.01% 150
2017
Q4 		$3K Hold
8
– – ﹤0.01% 148
2017
Q3 		$4K Hold
8
– – ﹤0.01% 158
2017
Q2 		$4K Sell
8
-39
-83% -$17.1K ﹤0.01% 160
2017
Q1 		$18K Hold
47
– – 0.01% 105
2016
Q4 		$17K Hold
47
– – 0.01% 101
2016
Q3 		$19K Hold
47
– – 0.01% 96
2016
Q2 		$16K Hold
47
– – 0.01% 96
2016
Q1 		$17K Hold
47
– – 0.02% 86
2015
Q4 		$26K Buy
+47
New +$25.5K 0.02% 75

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

D. Scott Neal's REGN Position: Q2 2018 in Review

D. Scott Neal sold out of Regeneron Pharmaceuticals (REGN) in Q2 2018, closing a stake of 8 shares — an estimated $3K sold.

D. Scott Neal first reported a position in REGN in Q4 2015 and held it in 10 quarters. The position peaked at $26K in Q4 2015. 624 funds tracked by Wall St. Rank hold REGN as of Q2 2018.

  • D. Scott Neal reported no remaining Regeneron Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • D. Scott Neal sold 8 Regeneron Pharmaceuticals shares in Q2 2018, an estimated $3K.
  • D. Scott Neal first reported a position in Regeneron Pharmaceuticals in Q4 2015 and held it in 10 quarters.
  • D. Scott Neal's Regeneron Pharmaceuticals position peaked at $26K in Q4 2015.
  • 624 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2018.

Based on D. Scott Neal's 13F filing for Q2 2018, filed 15 Aug 2018.